NSE 500 — The Filing Layer   CompaniesFilings

Caplin Point Laboratories Ltd.

CAPLIPOINTHealthcare filings

We hold this company’s filings and have not read the financial statements out of them yet. Every filing on record is listed under filings, and each one opens.

Earnings calls

14 transcript(s)/analyst meet(s) served; 20 document(s) on file are not transcripts (cover letters, duplicates, unresolved) and are excluded. Speaker attribution is shown only where the segmenter attributes ≥ 95% of sentences to management or analysts (0 of 14 documents here); elsewhere sentences render unattributed.

KindDatePeriodServedAttribution rate
COVER_LETTER202306022023-03-31no
COVER_LETTER202308162023-06-30no
COVER_LETTER202408142023-06-30no
COVER_LETTER202311172023-09-30no
COVER_LETTER202402162023-12-31no
COVER_LETTER202405232024-03-31no
TRANSCRIPT202505222024-03-31yes
TRANSCRIPT202408142024-06-30yes
DUPLICATE202408142024-06-30no
TRANSCRIPT202411142024-09-30yes
COVER_LETTER202411142024-09-30no
COVER_LETTER202511122024-09-30no
DUPLICATE202511122024-09-30no
COVER_LETTER202502142024-12-31no
COVER_LETTER202602112024-12-31no
COVER_LETTER202505222025-03-31no
DUPLICATE202505222025-03-31no
COVER_LETTER202605212025-03-31no
TRANSCRIPT202508142025-06-30yes
COVER_LETTER202508142025-06-30no
COVER_LETTER202608192025-06-30no
DUPLICATE202602112025-12-31no
TRANSCRIPT202605212026-03-31yes
DUPLICATE202605212026-03-31no
DUPLICATE202608192026-06-30no

CAPLIPOINT

files the standard Schedule III statements. Every figure below opens to the filing it was read from; where a figure is not shown, the reason is printed in its place.

Identity

Statement divisiongeneral
Scope servedconsolidated
Panels on this page4

Market

No split, bonus or consolidation is on record for this company inside the period this price series covers, so the closes need no adjustment.

Last close2,867.40
52-week range1504.8 – 2867.4
Return 1M16.0%
Return 3M14.4%
Return 1Y26.81%
Return 3Y187.36%
Return 5Y222.67%
Market capitalisationnot shown — we could not confirm it
Shares outstandingnot shown — we could not confirm it
P/Enot shown — we could not confirm it
P/Bnot shown — we could not confirm it
EV/EBITDAnot shown — we could not confirm it

Latest quarter filed — period ending 2026-06-30

In INR crore except per-share figures. `period_id` is the period the filing names for the number; the date beside each cell is when it was filed.

Revenue from operations610.00
Other income34.00
Total income644.00
Cost of materials consumed107.00
Purchases of stock-in-trade196.00
Changes in inventories-58.00
Employee benefit expense54.00
Finance costs0.00

Ownership — 2026-06-30, and the change from 2026-03-31

HolderPer centChange
promoter and promoter group0.710.00
institutions foreign0.06-0.00
institutions domestic0.020.00
mutual funds0.020.00
public0.290.00

Documents on file

ClassMost recentOn file
COVER_LETTER2025-06-3014
DUPLICATE2026-06-306
TRANSCRIPT2026-03-315

Financial statements

Filed results, consolidated, in INR crore except per-share figures. Every figure opens to the filing it was read from. Quarterly and annual columns are the periods the filing itself names, never a document date.

Quarterly results, as filed

Line2022-09-302022-12-312023-03-312023-06-302023-09-302023-12-312024-03-312024-06-302024-09-302024-12-312025-03-312025-06-302025-09-302025-12-312026-03-312026-06-30
Revenue from operations359.00372.00389.00395.00410.00436.00453.00459.00483.00493.00502.00510.00534.00543.00600.00610.00
Other income16.0014.0011.0012.0020.0017.0017.0019.0021.0031.0026.0023.0030.0034.0028.0034.00
Total income376.00386.00401.00407.00430.00453.00471.00478.00504.00524.00528.00533.00564.00576.00629.00644.00
Cost of materials consumed54.0057.0057.0064.0067.0051.0058.0064.0069.0060.0061.0074.0092.0089.00102.00107.00
Purchases of stock-in-trade153.00105.00106.00128.00129.00180.00122.0074.00122.00139.00139.00114.00122.00128.00209.00196.00
Changes in inventories-42.003.0013.00-14.00-32.00-41.0012.0047.00-3.00-4.002.008.00-4.00-2.00-66.00-58.00
Employee benefit expense34.0035.0036.0035.0035.0037.0037.0040.0044.0047.0047.0043.0047.0050.0053.0054.00
Finance costs0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation and amortisation11.0011.0011.0011.0012.0014.0016.0016.0017.0016.0017.0016.0018.0019.0019.0022.00
Other expenses54.0064.0053.0055.0073.0066.0080.0082.0085.0089.0087.0094.0087.0088.0098.0098.00
Total expenses265.00274.00277.00280.00285.00307.00325.00323.00335.00347.00352.00349.00363.00373.00415.00419.00
Profit before exceptional items and tax110.00112.00124.00127.00146.00145.00146.00154.00169.00177.00177.00184.00201.00204.00213.00225.00
Exceptional items0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax110.00112.00124.00127.00146.00145.00146.00154.00169.00177.00177.00184.00201.00204.00213.00225.00
Current tax19.0019.0024.0024.0031.0026.0021.0029.0032.0034.0029.0033.0037.0036.0041.0046.00
Deferred tax-1.00-5.00-1.00-2.00-1.00-0.004.000.005.003.002.001.004.002.00-0.00-0.00
Tax expense18.0014.0023.0023.0030.0026.0025.0029.0038.0037.0031.0034.0041.0038.0041.0046.00
Profit for the period92.0097.00101.00104.00116.00120.00121.00125.00131.00140.00145.00151.00160.00166.00173.00179.00
Profit attributable to owners92.0097.00102.00103.00115.00117.00122.00124.00131.00139.00141.00153.00154.00164.00170.00177.00
Profit attributable to non-controlling interests0.00-0.00-1.001.001.003.00-0.001.000.001.003.00-2.006.002.003.002.00
Other comprehensive income17.009.00-5.00-2.0010.001.003.005.001.0023.00-2.000.0048.0017.0077.00-2.00
Total comprehensive income109.00107.0096.00102.00126.00121.00124.00130.00132.00163.00144.00151.00208.00183.00250.00177.00
Earnings per share, basic12.0912.8613.4513.6215.1315.4416.0116.3217.2218.2818.7520.1020.3221.5622.3823.27
Earnings per share, diluted11.9912.7513.3313.5515.0615.3915.9016.2417.1218.1918.6920.0320.2521.5122.3123.21

Annual results, as filed

Line2018-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Revenue from operations540.00863.001,061.001,269.001,467.001,694.001,937.002,187.00
Other income13.0041.0024.0039.0056.0067.0096.00116.00
Total income553.00905.001,085.001,308.001,523.001,761.002,034.002,303.00
Cost of materials consumed90.00108.00130.00192.00223.00240.00248.00357.00
Purchases of stock-in-trade150.00500.00260.00397.00519.00559.00576.00572.00
Changes in inventories-2.00-195.0082.00-32.00-79.00-75.00-53.00-64.00
Employee benefit expense39.0068.00103.00115.00137.00144.00178.00199.00
Finance costs0.000.002.001.001.001.001.001.00
Depreciation and amortisation19.0032.0037.0047.0045.0053.0066.0073.00
Other expenses68.00122.00158.00202.00225.00275.00342.00362.00
Total expenses364.00635.00771.00922.001,071.001,197.001,357.001,500.00
Profit before exceptional items and tax188.00269.00314.00386.00451.00564.00677.00803.00
Exceptional items0.000.000.000.000.000.000.000.00
Profit before tax188.00269.00314.00386.00451.00564.00677.00803.00
Current tax41.0062.0071.0084.0082.00102.00125.00146.00
Deferred tax3.00-7.00-9.00-7.00-8.001.0010.007.00
Tax expense44.0054.0062.0077.0074.00103.00136.00153.00
Profit for the period145.00215.00251.00308.00377.00461.00541.00650.00
Profit attributable to owners145.00215.00242.00—376.00457.00563.00641.00
Profit attributable to non-controlling interests-0.000.009.00—1.004.005.008.00
Other comprehensive income1.0017.00-7.0014.0043.0011.0027.00142.00
Total comprehensive income145.00232.00244.00323.00420.00473.00568.00791.00
Earnings per share, basic19.2628.4232.0339.6149.6260.1970.5784.36
Earnings per share, diluted19.1628.2031.7139.2649.1859.9070.2584.11

Balance sheet, as filed

Line2022-09-302023-03-312023-09-302024-03-312024-09-302025-03-312025-09-302026-03-31
Total assets2,021.002,191.002,413.002,697.002,924.003,209.003,504.004,045.00
Non-current assets477.00637.00745.00805.00925.001,075.001,176.001,460.00
Current assets1,544.001,554.001,668.001,892.001,999.002,134.002,328.002,586.00
Property, plant and equipment273.00267.00269.00439.00452.00530.00523.00547.00
Capital work-in-progress55.00220.00275.00117.00153.00139.00177.00209.00
Goodwill0.000.000.000.000.000.000.000.00
Other intangible assets9.0011.0010.0013.0012.0011.0026.0033.00
Inventories296.00288.00337.00363.00327.00336.00329.00429.00
Trade receivables371.00394.00459.00543.00618.00632.00694.00826.00
Cash and cash equivalents374.00178.00138.00139.00177.00199.00108.0094.00
Total equity and liabilities2,021.002,191.002,413.002,697.002,924.003,209.003,504.004,045.00
Equity1,713.001,907.002,102.002,347.002,575.002,886.003,199.003,631.00
Equity share capital15.0015.0015.0015.0015.0015.0015.0015.00
Other equity1,671.001,865.002,058.002,301.002,527.002,835.003,144.003,571.00
Total liabilities308.00284.00310.00351.00350.00322.00305.00415.00
Non-current liabilities13.0016.0016.0020.0020.0016.0020.0029.00
Current liabilities294.00268.00294.00331.00329.00306.00285.00386.00
Borrowings, non-current0.000.000.001.000.000.000.000.00
Borrowings, current0.003.002.000.001.001.000.001.00
Trade payables174.00164.00171.00209.00214.00218.00209.00296.00

Cash flow, as filed

Line2022-09-302023-03-312023-09-302024-03-312024-09-302025-03-312025-09-302026-03-31
Net cash from operating activities141.00272.00129.00311.00186.00432.00254.00523.00
Net cash from investing activities-80.00-218.00-153.00-313.00-130.00-335.00-299.00-582.00
Net cash from financing activities-16.00-28.00-17.00-38.00-19.00-38.00-46.00-46.00
Purchase of property, plant and equipment53.00194.0079.00146.0077.00192.0094.00248.00
Net increase in cash47.0027.00-40.00-39.0038.0059.00-91.00-105.00
con:CFO.BEFORE_TAX184.00363.00177.00424.00247.00563.00318.00668.00
con:INTEREST_RECEIVED.OPERATING0.000.000.000.000.000.000.000.00
con:INTEREST_PAID.OPERATING0.000.000.000.000.000.000.000.00
con:DIVIDENDS_RECEIVED.OPERATING0.000.000.000.000.000.000.000.00
con:TAX_PAID.OPERATING42.0088.0048.00109.0062.00131.0065.00144.00
con:CF_OTHER.OPERATING0.00-3.000.00-4.000.000.000.000.00
con:INVESTMENTS_PURCHASED54.00141.0016.0094.00138.00214.000.00268.00
con:INVESTMENTS_SOLD18.000.000.000.000.000.000.000.00
con:PPE_DISPOSALS0.000.000.000.000.000.000.000.00
con:CF_INVESTING.SUBSIDIARIES_SOLD0.000.000.000.000.000.000.000.00
con:CF_INVESTING.SUBSIDIARIES_ACQUIRED0.000.000.000.000.000.000.000.00
con:CF_INVESTING.JV_SOLD0.000.000.000.000.000.000.000.00
con:CF_INVESTING.JV_ACQUIRED0.000.000.000.000.000.000.000.00

Who owns it

The shareholding pattern filed with the exchange every quarter, as a series. Percentages are of total shares. Each figure names the filing it was read from and the date it was filed.

Holder2023-03-312023-06-302023-09-302023-12-312024-03-312024-06-302024-09-302024-12-312025-03-312025-06-302025-09-302025-12-312026-03-312026-06-30
Promoter and promoter group70.6670.6370.6370.6270.6270.5670.5670.5670.5670.560.710.710.710.71
Domestic institutions0.650.260.200.431.091.491.842.112.012.220.020.020.020.02
Mutual funds—————————1.930.020.020.020.02
Insurance companies0.000.000.130.000.000.080.150.140.200.220.000.000.000.00
Foreign institutions2.362.693.092.853.343.373.704.865.736.170.070.070.060.06
Government————————————0.000.00
Public29.3429.3729.3729.3829.3829.4429.4429.4429.4429.440.290.290.290.29
Non-institutional26.3426.4226.0826.1024.9524.5723.9022.4721.7021.050.210.210.210.21
Shares outstanding7590274675933746759397467594174675941746760102967601169676011696760116967601169676011696760116967601169676011696

Related parties

Transactions with related parties as disclosed to the exchange for the period ending 2024-09-30, by counterparty, largest first. Amounts are as filed. Each row names the filing and the date it was filed.

CounterpartyRelationshipTypeAmount in the periodTransactions
Nuevos Eticos Neo Ethicals S.A - GuatemalaStep Down SubsidiarySale of goods or services1,658,000,000.004
Caplin One Labs Limited (Formerly Known as Caplin Onco LimitWholly owned SubsidiaryAny other transaction, Interest received, Loan, Sale1,122,600,000.008
Neo Ethicals S.A - NicaraguaWholly owned step down SubsidiaryPurchase of goods or services, Sale of goods or serv841,700,000.006
Caplin Steriles LimitedSubsidiaryAny other transaction, Interest received, Loan, Purc652,500,000.009
Drogueria Saimed de Honduras S.AWholly owned step down SubsidiaryPurchase of goods or services, Sale of goods or serv246,100,000.006
Caplin Steriles USA Inc.Wholly owned Subsidiary CompanyAny other transaction134,100,000.001
Neoethicals CIA.LTDA - EcuadorWholly owned step down SubsidiaryPurchase of goods or services, Sale of goods or serv131,200,000.005
Caplin Point Meenakshi CSR TrustTrust in which Promoter/ Promoter Any other transaction52,400,000.001
Argus Salud Pharma LLPSubsidiaryAny other transaction, Sale of goods or services51,000,000.002
Mr. Ashok Gorkey PartheebanBusiness Head LatamRemuneration12,500,000.001
Sunsole Solar Private LimitedAssociate CompanyPurchase of goods or services11,700,000.001
Ashvich Infotek Private LimitedDirectors and their relatives are Any other transaction11,400,000.003
Mr. M Sathya NarayananKey Management PersonnelAny other transaction, Remuneration8,700,000.002
Dr.Gunasakaran SambandanRelated Party of the subsidiaryAny other transaction, Remuneration4,000,000.003
Mr. Venkatram GKey Management PersonnelAny other transaction, Remuneration3,200,000.002